GFAP and B-cell chronic lymphocytic leukemia: Consistent with this report, we observed that MG in CLL did not significantly upregulate the expression of the intermediate filament GFAP, which is a hallmark of reactive gliosis (Figures 5B–H, Q) (Thomas et al., 2016; Ranski et al., 2018).